CHSB — Himsnab Bulgaria AD Income Statement
0.000.00%
- €87.31m
- €102.65m
- BGN60.21m
Annual income statement for Himsnab Bulgaria AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 32.6 | 40.2 | 64.7 | 61.3 | 60.2 |
| Cost of Revenue | |||||
| Gross Profit | 9.63 | 12.1 | 18.9 | 17.4 | 17.6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 27.1 | 33.3 | 53.6 | 54.8 | 51.7 |
| Operating Profit | 5.51 | 6.99 | 11.1 | 6.45 | 8.46 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 5.18 | 6.92 | 11.5 | 7.58 | 10.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.61 | 5.93 | 10 | 5.74 | 10 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4.03 | 4.83 | 8.57 | 5.53 | 9.08 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4.03 | 4.83 | 8.57 | 5.53 | 9.08 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.62 | 1.93 | 3.44 | 2.22 | 3.64 |
| Dividends per Share |